Corticobasal degeneration (CBD) is a rare neurodegenerative disease characterized by dystonia, cognitive deficits, and an asymmetric akinetic-rigid syndrome. Little information is available regarding anesthetic management for CBD patients. Our patient was a 55-year-old man with CBD complicated by central sleep apnea (CSA). Due to the risk of perioperative breathing instability associated with anesthetic use, a laryngeal mask airway was used during anesthesia with propofol. Spontaneous respiration was stable under general anesthesia. However, respiratory depression occurred following surgery, necessitating insertion of a nasopharyngeal airway. Since no respiratory depression had occurred during maintenance of the airway using the laryngeal mask, we suspected an upper airway obstruction caused by displacement of the tongue due to residual propofol. Residual anesthetics may cause postoperative respiratory depression in patients with CBD. Therefore, continuous postoperative monitoring of SpO2 and preparations to support postoperative ventilation are necessary.
INTRODUCTION
Corticobasal degeneration (CBD) is a rare neurodegenerative disease with a distinctive clinical picture, including features related to both cortical and basal ganglia dysfunction [1] . Some characteristic signs of CBD include asymmetric upper limb dystonia, cognitive deficits, myoclonus, gait abnormalities, and asymmetric akinetic-rigid syndrome [2] . CBD patients may develop rigidity and dystonia, thereby necessitating anesthetic management for dental treatment. Few reports have discussed anesthetic management in CBD patients.
Central sleep apnea (CSA) encompasses a wide range of conditions resulting in the cessation of airflow without respiratory effort [3] . CSA can be provoked or exacerbated by the effects of sedative and anesthetic agents.
This report describes our experience with general anesthesia for dental treatment in a patient with CBD complicated by CSA. We obtained informed consent from the patient's legal guardian.
CASE PRESENTATION
The patient was a 55-year-old man with a body weight He visited our hospital due to pain in the oral cavity.
He exhibited marked dystonia in the upper limb and orofacial areas. He was confined to a wheelchair and required assistance to eat, use the toilet, and get dressed and undressed. Brushing his teeth was also difficult; his toothbrush broke in his mouth due to oral rigidity. Since normal dental care was impossible, he underwent tooth scaling and several extractions under general anesthesia. 
DISCUSSION
CBD is a relentlessly progressive neurodegenerative condition with a mean disease survival rate of approximately seven years [1] , although the shortest reported duration of survival was 24 months [4] . Previous criteria for CBD reflected a single phenotype only: CBS, which was thought to be pathognomonic for CBD. However, CBS is a CBD phenotype, and new criteria have been developed for other phenotypes [1] . CBD is associated with asymmetric upper limb dystonia, alien limb phenomenon, myoclonus, dysarthria, eye movement disturbance, gait abnormalities, and cognitive-behavioral and/or language disorders (i.e., CBS) [2] . The clinical diagnosis of CBS may be supported by the results of different neuroimaging and neurophysiological investigations, since asymmetric frontoparietal atrophy can be observed during magnetic resonance imaging [5] . Single-photon emission computed tomography can also be used to observe hypoperfusion and hypometabolism in the frontoparietal regions in CBS patients [6] .
Dental procedures may be difficult in CBD patients due to dystonia in the orofacial area. Thus anesthetic management is necessary. However, there are no guidelines for anesthetic management in CBD patients. Given the progressive nature of CBD, it is difficult to predict responses to anesthetic agents. An additional complication of the present case was CSA, which is occasionally observed in patients with neurological disorders. CSA results from a reduction in output from the central respiratory generator in the brainstem, manifesting as apnea and hypopnea without discernible effort [3] . CSA patients experience hypoventilation during sleep; the ventilatory drive is reduced and compensatory mechanisms fail [7] . Therefore, administration of sedative and anesthetic agents may worsen CSA or induce sleep apnea [8] . Since the patient was prone to problems with respiratory status after general anesthesia and was at risk for hypercapnia and apnea, we chose anesthetic management by spontaneous breathing to avoid postoperative respiratory depression. Furthermore, his respiratory state after surgery could be predicted from the state of spontaneous breathing during anesthesia. An LMA was chosen because it can be inserted without the use of a muscle relaxant, allowing for rapid recovery of spontaneous breathing. Additionally, anesthetic management with LMA requires less total anesthetic dose. Although further studies are required to determine the comparative advantages/disadvantages of intravenous or inhaled anesthetic agents, we selected propofol due to its short, context-sensitive half-life [9] and ability to suppress pharyngeal reflex.
No apneas/hypopneas were observed during the procedures, and spontaneous respiration was stable. However, despite the removal of the LMA after adequate emergence, respiratory depression occurred after surgery.
Since no respiratory depression was observed during airway maintenance using the LMA, CSA was unlikely In a meta-analysis of the incidence of LMA and aspiration pneumonia, only three out of 112,901 patients experienced aspiration, suggesting that LMA use does not increase the risk of aspiration, unlike tracheal intubation [12] . Dysphagia is a frequent complication in advanced 
